Literature DB >> 31451494

Structural Insights into Catalytic Relevances of Substrate Poses in ACC-1.

Da-Woon Bae1, Ye-Eun Jung1, Young Jun An2, Jung-Hyun Na1, Sun-Shin Cha3.   

Abstract

ACC-1 is a plasmid-encoded class C β-lactamase identified in clinical isolates of Klebsiella pneumoniae, Proteus mirabilis, Salmonella enterica, and Escherichia coli ACC-1-producing bacteria are susceptible to cefoxitin, whereas they are resistant to oxyimino cephalosporins. Here, we depict crystal structures of apo ACC-1, adenylylated ACC-1, and acylated ACC-1 complexed with cefotaxime and cefoxitin. ACC-1 has noteworthy structural alterations in the R2 loop, the Ω loop, and the Phe119 loop located along the active-site rim. The adenylate covalently bonded to the nucleophilic serine reveals a tetrahedral phosphorus mimicking the deacylation transition state. Cefotaxime in ACC-1 has a proper conformation for the substrate-assisted catalysis in that its C-4 carboxylate and N-5 nitrogen are adequately located to facilitate the deacylation reaction. In contrast, cefoxitin in ACC-1 has a distinct conformation, in which those functional groups cannot contribute to catalysis. Furthermore, the orientation of the deacylating water relative to the acyl carbonyl group in ACC-1 is unfavorable for nucleophilic attack.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  ACC-1 class C β-lactamase; acyl-enzyme complex; adenylylation; cefotaxime; cefoxitin; crystal structures

Year:  2019        PMID: 31451494      PMCID: PMC6811428          DOI: 10.1128/AAC.01411-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  A clogged gutter mechanism for protease inhibitors.

Authors:  Evette S Radisky; Daniel E Koshland
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-25       Impact factor: 11.205

2.  Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients.

Authors:  Salomon Ohana; Veronique Leflon; Esthel Ronco; Martin Rottman; Didier Guillemot; Sylvie Lortat-Jacob; Pierre Denys; Georges Loubert; Marie-Helène Nicolas-Chanoine; Jean-Louis Gaillard; Christine Lawrence
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 3.  Extended-spectrum cephalosporinases: structure, detection and epidemiology.

Authors:  Patrice Nordmann; Hedi Mammeri
Journal:  Future Microbiol       Date:  2007-06       Impact factor: 3.165

4.  Molecular replacement with MOLREP.

Authors:  Alexei Vagin; Alexei Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

5.  Structural basis for the extended substrate spectrum of AmpC BER and structure-guided discovery of the inhibition activity of citrate against the class C β-lactamases AmpC BER and CMY-10.

Authors:  Jung Hyun Na; Sun Shin Cha
Journal:  Acta Crystallogr D Struct Biol       Date:  2016-07-28       Impact factor: 7.652

6.  In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.

Authors:  Philippe Bidet; Béatrice Burghoffer; Valérie Gautier; Naïma Brahimi; Patricia Mariani-Kurkdjian; Alaa El-Ghoneimi; Edouard Bingen; Guillaume Arlet
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

7.  The deacylation mechanism of AmpC beta-lactamase at ultrahigh resolution.

Authors:  Yu Chen; George Minasov; Tomer A Roth; Fabio Prati; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2006-03-08       Impact factor: 15.419

8.  Heterogeneity of AmpC cephalosporinases of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance phenotypes.

Authors:  D Girlich; T Naas; S Bellais; L Poirel; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

9.  Cefoxitin sensitivity as a marker for inducible beta-lactamases.

Authors:  V A Moritz; P B Carson
Journal:  J Med Microbiol       Date:  1986-05       Impact factor: 2.472

10.  Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: possible implications for the oxyanion hypothesis and for inhibitor design.

Authors:  K C Usher; L C Blaszczak; G S Weston; B K Shoichet; S J Remington
Journal:  Biochemistry       Date:  1998-11-17       Impact factor: 3.162

View more
  3 in total

Review 1.  Class C β-Lactamases: Molecular Characteristics.

Authors:  Alain Philippon; Guillaume Arlet; Roger Labia; Bogdan I Iorga
Journal:  Clin Microbiol Rev       Date:  2022-04-18       Impact factor: 50.129

2.  Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.

Authors:  Thanh Bach; Guohua An
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-04-21       Impact factor: 2.745

Review 3.  The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria.

Authors:  Dalal Hammoudi Halat; Carole Ayoub Moubareck
Journal:  Antibiotics (Basel)       Date:  2020-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.